Physician profile
Laura E Oehler
NPI 1508347766
$7,323.05
in general payments reported to CMS, 2019-2025
38 companies · $1,785 in 2025
The $1,785 reported for 2025 was more than what 94% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $564 · 2022: $1,147 · 2023: $1,462 · 2024: $2,365 · 2025: $1,785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,611.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $770.87 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $673.17 | 2021-2024 | Xarelto, Spravato |
| Lilly USA, LLC | $537.79 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $479.85 | 2022-2025 | Airsupra, Farxiga, Fasenra |
| Novo Nordisk INC | $393.40 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $368.50 | 2022-2025 | Arexvy, Shingrix, Trelegy Ellipta |
| Phathom Pharmaceuticals, INC. | $361.49 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $327.46 | 2024-2025 | |
| Nevro Corp. | $322.26 | 2022-2023 | Senza |
| Shield Therapeutics INC | $273.93 | 2024 | |
| Exact Sciences Corporation | $251.87 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Axsome Therapeutics, INC. | $246.78 | 2024-2025 | Auvelity |
| Inspire Medical Systems, INC. | $239.93 | 2024-2025 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $160.71 | 2021-2024 | Jardiance, Synjardy |
| Amgen INC. | $155.12 | 2023-2025 | Evenity, Otezla, Repatha |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Oehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.